Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p28
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 28/191)
Character Range: 9767481–9782265

for facial administration only; AND
                                                                                                                                                                                                                               The condition must be caused by therapy for HIV infection.
                                                                                                                                                                                                                               Accreditation following completion of injection administration training with Galderma is required to prescribe poly-l-lactic acid under the PBS. Patients must be referred from the HIV physician to the accredited injector.
C5123               P5123          CN5123           Sodium acid phosphate                                                                                                                                                      Hypercalcaemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures - Streamlined Authority Code 5123

C5130               P5130          CN5130           Mesna                                                                                                                                                                      Urothelial toxicity
                                                                                                                                                                                                                               Prophylaxis or reduction of toxicity
                                                                                                                                                                                                                               The treatment must be adjunctive therapy to ifosfamide or high dose cyclophosphamide.
C5131               P5131          CN5131           Pramipexole                                                                                                                                                                Parkinson disease

C5132               P5132          CN5132           Amantadine                                                                                                                                                                 Parkinson disease
                                                                                                                                                                                                                               The condition must not be drug induced.
C5133               P5133          CN5133           Entacapone                                                                                                                                                                 Parkinson disease
                                                                                                                                                                                                                               The treatment must be as adjunctive therapy to a levodopa-decarboxylase inhibitor combination; AND
                                                    Opicapone                                                                                                                                                                  Patient must be experiencing fluctuations in motor function due to end-of-dose effect.

C5135               P5135          CN5135           Levonorgestrel                                                                                                                                                             Idiopathic menorrhagia
                                                                                                                                                                                                                               The treatment must be in a patient where oral treatments are ineffective.
C5136               P5136          CN5136           Cabergoline                                                                                                                                                                Pathological hyperprolactinaemia
                                                                                                                                                                                                                               Patient must be one in whom surgery is not indicated.
                                                    Quinagolide

C5137               P5137          CN5137           Cabergoline                                                                                                                                                                Pathological hyperprolactinaemia
                                                                                                                                                                                                                               Patient must have had surgery for this condition with incomplete resolution.
                                                    Quinagolide

C5139               P5139          CN5139           Thiamine                                                                                                                                                                   Thiamine deficiency                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Authority Required procedures - Streamlined Authority Code 5139
                                                                                                                                                                                                                               The treatment must be for prophylaxis;
                                                                                                                                                                                                                               Patient must be an Aboriginal or a Torres Strait Islander person.
C5140               P5140          CN5140           Nicotine                                                                                                                                                                   Nicotine dependence
                                                                                                                                                                                                                               Patient must be an Aboriginal or a Torres Strait Islander person;
                                                                                                                                                                                                                               The treatment must be the sole PBS-subsidised therapy for this condition.
C5141               P5141          CN5141           Eletriptan                                                                                                                                                                 Migraine attack
                                                                                                                                                                                                                               The condition must have usually failed to respond to analgesics in the past.
C5168               P5168          CN5168           Cabergoline                                                                                                                                                                Parkinson disease

C5172               P5172          CN5172           Bromocriptine                                                                                                                                                              Prevention of the onset of lactation
                                                                                                                                                                                                                               The treatment must occur in the puerperium; AND
                                                    Cabergoline                                                                                                                                                                The treatment must be for medical reasons.

C5173               P5173          CN5173           Topiramate                                                                                                                                                                 Seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures - Streamlined Authority Code 5173
                                                                                                                                                                                                                               Patient must have partial epileptic seizures; or
                                                                                                                                                                                                                               Patient must have primary generalised tonic-clonic seizures; or
                                                                                                                                                                                                                               Patient must have seizures of the Lennox-Gastaut syndrome; AND
                                                                                                                                                                                                                               The condition must have failed to be controlled satisfactorily by other anti-epileptic drugs; AND
                                                                                                                                                                                                                               Patient must be unable to take a solid dose form of topiramate.
C5174               P5174          CN5174           Insulin detemir                                                                                                                                                            Type 1 diabetes

C5177               P5177          CN5177           Minoxidil                                                                                                                                                                  Severe refractory hypertension
                                                                                                                                                                                                                               The treatment must be initiated by a consultant physician.
C5178               P5178          CN5178           Botulinum toxin type A purified neurotoxin complex                                                                                                                         Moderate to severe spasticity of the upper limb                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 5178
                                                                                                                                                                                                                               Patient must have cerebral palsy;
                                                    Clostridium botulinum type A toxin - haemagglutinin complex                                                                                                                Patient must be aged from 2 to 17 years inclusive;
                                                                                                                                                                                                                               Must be treated by a neurologist.  or
                                                                                                                                                                                                                               Must be